SCOPE-AD: Sequential cost-aware ordinal-belief planning with energy-based models for diagnostic agents
Alzheimer's disease (AD) diagnosis requires sequential evidence acquisition under heterogeneous test costs and patient burden. Fixed-modality predictors do not jointly decide which test to acquire or when the available evidence is sufficient for diagnosis. We propose SCOPE-AD (Sequential Cost-Aware Ordinal-Belief Planning with Energy-Based Models for Diagnostic Agents) for cost-aware…
We haven't written up this one. arXiv cs.AI has the full story — the link below goes straight to it.
